Inhibitor Therapeutics | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

34,564 results for “Inhibitor Therapeutics”

Trials

View all 13280 →

Active, not recruiting

Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer

8 participants · First posted Mar 9, 2023

EMDR on Pain in Patients With in Patients Rheumatoid Arthritis

64 participants · First posted Jul 13, 2023

Clinical Performance of BIS-GMA Free Dental Resin Composite

40 participants · First posted Jul 29, 2022

Drugs

View all 6919 →

DHODH inhibitor (PTC Therapeutics)

YAP-TEAD Program (Beactica Therapeutics)

CSF1R inhibitor (Myrobalan Therapeutics)

Organizations

View all 1131 →

Inhibikase Therapeutics

United States

Odyssey Therapeutics

Quince Therapeutics

United States

News

View all 13234 →

Inhibitor Therapeutics Advances Itraconazole Program for Gorlin Syndrome with Novel Amorphous Formulation

Inhibitor Therapeutics Advances Itraconazole for Gorlin Syndrome, Reports 0.265 New Surgically Eligible BCCs Per Patient-Year

Inhibikase Therapeutics Secures $275M Financing, Advances IkT-001Pro for Pulmonary Arterial Hypertension

Page 1 of 3457